Hernan Bazan, MD
Vascular Surgery · San Francisco, CANPI 1073714358
Payments from drug & device makers
Across 78 payments — averaging $137.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$5K
- W. L. Gore & Associates, Inc.$4K
- KCI USA, Inc.$800
- Cook Medical LLC$245
- Silk Road Medical, Inc.$200
- Philips North America LLC$179
- plus $670 from 9 others
What the payments were for
- Consulting fees$1,20011%
- Speaking & faculty fees$3,20030%
- Travel & lodging$621%
- Food & beverage$6,27558%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 17 | $4,687 |
| W. L. Gore & Associates, Inc. | 36 | $3,956 |
| KCI USA, Inc. | 1 | $800 |
| Cook Medical LLC | 7 | $245 |
| Silk Road Medical, Inc. | 2 | $200 |
| Philips North America LLC | 3 | $179 |
| Surmodics, Inc. | 3 | $171 |
| Penumbra, Inc. | 1 | $146 |
| Imperative Care, Inc | 1 | $143 |
| Cardiovascular Systems Inc. | 1 | $49 |
| Bolton Medical Inc | 1 | $44 |
| Shockwave Medical, Inc | 1 | $40 |
| Argon Medical Devices, Inc. | 2 | $29 |
| Abbott | 1 | $27 |
| Angiodynamics, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MO.MA ULTRA$3,200
- GORE VIABAHN VBX Balloon Expandable Endo$1,322
- PREVENA$800
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$754
- ENDURANT IIS$670
- VIABAHN Endoprosthesis with Heparin Bioactive Surface$383
- ENROUTE Transcarotid Neuroprotection System$359
- GORE TAG Thoracic Branch Endoprosthesis$327
- EXCLUDER AAA Endoprosthesis$257
- GORE EXCLUDER AAA Endoprosthesis$197
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$180
- ENROUTE Transcarotid Stent$180
- Penumbra System$146
- SYMPHONY CATHETER$143
- Cook$140
- GORE VIABAHN Endoprosthesis with Heparin$139
- Abre$139
- Pounce Thrombectomy System$134
- Pounce Venous Thrombectomy System$134
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$126
How this compares
$10,737 in reported general payments places this provider in the 70th percentile of 519 vascular surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 11 | $6,471 |
| ClopidogrelClopidogrel Bisulfate | 131 | $1,145 |
| Cilostazol | 44 | $710 |
| Warfarin Sodium | 12 | $61 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in San Francisco
- Hong HuaSan Francisco$139K
- Linda ReillySan Francisco$105K
- Michael ConteSan Francisco$62K
- Daniel NathansonSan Francisco$60K
- Venita ChandraPalo Alto$947K
- Leigh Ann ObanionFresno$932K
- Sukgu HanLos Angeles$765K
- Mahmoud Malasla Jolla$508K
- Son DuongFountain Valley$503K
- Leo FongClovis$496K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.